ZA823635B - Crf and analogs - Google Patents

Crf and analogs

Info

Publication number
ZA823635B
ZA823635B ZA823635A ZA823635A ZA823635B ZA 823635 B ZA823635 B ZA 823635B ZA 823635 A ZA823635 A ZA 823635A ZA 823635 A ZA823635 A ZA 823635A ZA 823635 B ZA823635 B ZA 823635B
Authority
ZA
South Africa
Prior art keywords
glu
gln
leu
ala
lys
Prior art date
Application number
ZA823635A
Other languages
English (en)
Inventor
Wylie Walker Vale Jr
Catherine Laure Rivier
Joachim Spiess
Jean Edouard Frederick Rivier
Original Assignee
Sal Inst For Biolog Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sal Inst For Biolog Studi filed Critical Sal Inst For Biolog Studi
Publication of ZA823635B publication Critical patent/ZA823635B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57509Corticotropin releasing factor [CRF] (Urotensin)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Control Of Eletrric Generators (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Vehicle Body Suspensions (AREA)
ZA823635A 1981-06-08 1982-05-25 Crf and analogs ZA823635B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27162481A 1981-06-08 1981-06-08

Publications (1)

Publication Number Publication Date
ZA823635B true ZA823635B (en) 1983-03-30

Family

ID=23036364

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA823635A ZA823635B (en) 1981-06-08 1982-05-25 Crf and analogs

Country Status (15)

Country Link
EP (1) EP0067608B1 (xx)
JP (1) JPS57212149A (xx)
KR (1) KR890002774B1 (xx)
AT (1) ATE6505T1 (xx)
AU (1) AU554676B2 (xx)
CA (1) CA1243301A (xx)
DE (1) DE3260057D1 (xx)
DK (1) DK156957C (xx)
ES (1) ES8401446A1 (xx)
GR (1) GR75679B (xx)
IE (1) IE53488B1 (xx)
IL (1) IL65937A (xx)
NZ (1) NZ200711A (xx)
PH (1) PH20364A (xx)
ZA (1) ZA823635B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518391A1 (en) * 1984-02-23 1992-12-16 The Salk Institute For Biological Studies CRF analogs
CA1341051C (en) * 1988-09-23 2000-07-11 Jean Edouard Frederic Rivier Crf antagonists
CA2002004A1 (en) * 1988-11-14 1990-05-14 Karl P. Lederis Fish crf
US5235036A (en) * 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
DE4110422A1 (de) * 1991-03-29 1992-10-01 Bissendorf Peptide Gmbh Arzneimittel enthaltend humanes corticotropin-releasing hormon (crh) und/oder dessen derivate und/oder glucocorticoide natuerlicher und/oder synthetischer provenienz
US5830866A (en) * 1994-09-12 1998-11-03 The Trustees Of The University Of Pennsylvania Corticotropin release inhibiting factor and methods of using same
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
KR102259056B1 (ko) 2017-12-29 2021-06-01 (주)에스엠테크 디아민 화합물과 알루미네이트계 화합물을 포함하는 광물 미분쇄용 분쇄조제 조성물 및 이를 사용한 광물의 미분쇄방법
US11312804B2 (en) 2018-02-16 2022-04-26 Jnc Corporation Polymerizable compound, polymerizable composition, polymer, and photoresist composition

Also Published As

Publication number Publication date
ATE6505T1 (de) 1984-03-15
ES512892A0 (es) 1983-12-01
EP0067608A1 (en) 1982-12-22
CA1243301A (en) 1988-10-18
DK156957C (da) 1990-03-19
NZ200711A (en) 1986-02-21
EP0067608B1 (en) 1984-03-07
AU8445582A (en) 1982-12-16
KR890002774B1 (ko) 1989-07-28
IL65937A0 (en) 1982-09-30
JPS642600B2 (xx) 1989-01-18
IE53488B1 (en) 1988-11-23
DK254982A (da) 1982-12-09
GR75679B (xx) 1984-08-02
IE821330L (en) 1982-12-08
DE3260057D1 (en) 1984-04-12
IL65937A (en) 1986-09-30
AU554676B2 (en) 1986-08-28
PH20364A (en) 1986-12-04
ES8401446A1 (es) 1983-12-01
DK156957B (da) 1989-10-23
JPS57212149A (en) 1982-12-27
KR840000477A (ko) 1984-02-22

Similar Documents

Publication Publication Date Title
KR860006488A (ko) 펩티다제 억제물의 제조방법
DE3260057D1 (en) Crf and analogs
KR870007203A (ko) 펩타이드를 제조하는 방법
GB1585061A (en) Synthesis of peptides
KR880013977A (ko) 항응고제인 사이클릭 펩타이드
KR880013976A (ko) 항응고제인 사이클릭 펩타이드
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
KR830007516A (ko) 폴리펩타이드 조성물
AU574064B2 (en) Growth hormone releasing factor analogues
KR910007960A (ko) 항응고성 펩티드
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
KR900009699A (ko) 항응고성 펩타이드 및 이의 제조방법
IL61922A0 (en) Angiotensin-ii analogues containing an -hydroxycarboxylic acid residue in position 8,and process for the preparation thereof
GB992957A (en) New decapeptides and their manufacture
KR850700246A (ko) Crf 유사체
CA2076749A1 (en) Vasoactive vasotocin derivatives
GB1477001A (en) Process for the manufacture of peptides containing more han one cystine residue
US4389342A (en) Synthetic hormone-like peptides and method for their synthesis
CA1090784A (en) Synthesis for peptides
EP0147175A3 (en) Novel basic polypeptides and a method of producing thereof
GB1587809A (en) Synthesis of peptides
KR870007206A (ko) 폴리펩타이드 화합물
KR890002234A (ko) 혈관확장, 나트륨배설 및 이뇨활성을 지니는 펩타이드, 이의 제조방법, 이를 함유하는 제제, 및 이의 용도
KR910021412A (ko) 혈액 응고 억제 펩타이드, 이의 제조방법 및 이의 용도
KR850000980A (ko) 인슐린 유도체의 제조방법